Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin-Reference-Cited by-同舟云学术

Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin

Published:2015-06-30 Issue:7 Volume:4 Page:386-395
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

van Hasselt JGC¹²³,Gupta A⁴,Hussein Z⁴,Beijnen JH¹⁵,Schellens JHM²⁵,Huitema ADR¹²

Affiliation:

1. Department of Clinical PharmacologyNetherlands Cancer InstituteAmsterdam The Netherlands

2. Department of Pharmacy & PharmacologyNetherlands Cancer InstituteAmsterdam The Netherlands

3. Division of PharmacologyCluster Systems Pharmacology, Leiden Academic Centre for Drug Research, Leiden UniversityLeiden The Netherlands

4. Eisai LimitedHatfield UK

5. Faculty of Science Department of Pharmaceutical Sciences Division of Clinical Pharmacology and PharmacoepidemiologyUtrecht UniversityUtrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.49

Reference50 articles.

1. Prostate cancer incidence and mortality trends in 37 European countries: An overview

2. Cancer statistics, 2011

3. Contemporary Radical Prostatectomy

4. Radical Prostatectomy

5. Current and emerging treatments in the management of castration-resistant prostate cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model;EJNMMI Physics;2024-04-24

3. Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review;Frontiers in Oncology;2023-06-27

4. Identification of high‐dimensional omics‐derived predictors for tumor growth dynamics using machine learning and pharmacometric modeling;CPT: Pharmacometrics & Systems Pharmacology;2021-04

5. Biomarker‐Guided Individualization of Antibiotic Therapy;Clinical Pharmacology & Therapeutics;2021-03-02